Aciphex
- Product NDC
- 80725-243
- 11-digit product format
- 807250243
- Labeler code
- 80725
- Product ID
- 80725-243_cc6cb214-ac28-4c8b-9b57-7635ef896038
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rabeprazole sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Waylis Therapeutics LLC
- Application
- NDA020973
- Marketing category
- NDA
- Marketing start
- 2022-05-15
- Substance
- RABEPRAZOLE SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aciphex
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RABEPRAZOLE SODIUM | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3L36P16U4R |
| Rxcui | 854868, 854870 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80725-243-30 | Aciphex | 30 in 1 BOTTLE, PLASTIC | TABLET, DELAYED RELEASE | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80725-243 | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [WAYLIS THERAPEUTICS LLC] | 2 | Current NDC, 1 package rows | 20250129_1eb38279-0237-4967-be7a-c53a826c1138.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 80725-243-30 | 80725024330 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (80725-243-30) | 2023-12-01 | No | No | Historical |